Results for tag: "Visual Cycle Modulation Drug"

The Visual Cycle Modulation Drug market is a subset of the Optical Disorders Drugs market, which focuses on treatments for vision-related conditions. Visual Cycle Modulation Drugs are used to treat conditions such as age-related macular degeneration, retinitis pigmentosa, and diabetic macular edema. These drugs work by modulating the visual cycle, which is the process by which light is converted into a signal that is sent to the brain. This modulation helps to improve vision and reduce the risk of vision loss. The Visual Cycle Modulation Drug market is a rapidly growing sector, with many companies developing new treatments and technologies. Companies in this market include Regeneron Pharmaceuticals, Allergan, Novartis, and Roche. These companies are developing drugs and treatments that are designed to improve vision and reduce the risk of vision loss. Show Less Read more